For years, the name Wegovy meant a weekly injection. Anyone searching for Wegovy pills was looking for a tablet version that did not exist yet. That changed at the end of 2025: there is now a real Wegovy tablet, approved for weight management, with a price that depends heavily on where it is bought.
The gap is the whole story. The list price is over $1,300 a month, while the manufacturer’s own direct pharmacy sells the same pill for $149 to $299 a month.
Quick Answer
Without insurance, Wegovy pills cost $149 to $299 a month through NovoCare Pharmacy, Novo Nordisk’s own direct pharmacy, depending on the dose. The 25 mg maintenance dose costs $299 a month there. The list price is $1,349.02 for a four-week pack, and retail cash at a regular pharmacy runs about $1,349 to $1,599 a month.
What “Wegovy Pills” Actually Are
The Food and Drug Administration approved Wegovy tablets on December 22, 2025, as the first oral GLP-1 medicine approved for chronic weight management, and the United States launch followed in early January 2026. The pill contains semaglutide, the same active ingredient as the Wegovy injection, in tablet form.
The tablets come in four strengths: 1.5 mg, 4 mg, 9 mg, and 25 mg. Treatment starts at 1.5 mg daily, steps up to 4 mg after 30 days, then 9 mg after another 30 days, reaching the 25 mg maintenance dose from day 91. The slow step-up is designed to reduce stomach side effects.
The pill is taken once a day on an empty stomach with a small amount of water, no more than 4 ounces, followed by a 30-minute wait before food, drinks, or other pills.
Wegovy pills differ from Rybelsus, even though both contain oral semaglutide. Rybelsus is approved only for type 2 diabetes, at lower doses. Wegovy tablets are approved for weight management in adults with obesity, or with overweight and at least one weight-related condition, and to lower the risk of major heart events in adults with heart disease and overweight or obesity.
In the OASIS 4 trial, adults without diabetes on the 25 mg pill lost an average of 13.6 percent of body weight at 64 weeks, against 2.4 percent for placebo, counting everyone who started the trial.
How Much Wegovy Pills Cost Without Insurance
There is no single price for Wegovy pills without insurance. The amount depends on the dose and, more importantly, on where the prescription is filled: the manufacturer’s direct pharmacy charges far less than the list price, while a regular retail pharmacy charges close to it or more.
| Price route | Product and dose | Cost per month |
|---|---|---|
| List price | Pill or pen, four-week pack | $1,349.02 |
| NovoCare Pharmacy self-pay | Pill, 1.5 mg | $149 |
| NovoCare Pharmacy self-pay | Pill, 4 mg | $199 |
| NovoCare Pharmacy self-pay | Pill, 9 mg or 25 mg | $299 |
| NovoCare Pharmacy self-pay | Pen, 0.25 mg to 2.4 mg | $349 |
| NovoCare Pharmacy self-pay | Pen, new patients, first two fills of 0.25 mg or 0.5 mg | $199 |
| NovoCare Pharmacy self-pay | Wegovy HD pen, 7.2 mg | $399 |
| Retail cash, no program | Pill or pen at pharmacies such as CVS or Walgreens | About $1,349 to $1,599 |
NovoCare Pharmacy is Novo Nordisk’s own direct pharmacy. It sells to cash buyers with no insurance needed, though a prescription is still required. The pen costs $349 a month at any dose from 0.25 mg to 2.4 mg, and new patients pay $199 a month for their first two fills of the 0.25 mg and 0.5 mg pens, through December 31, 2026. NovoCare launched at $499 a month in March 2025, then cut the pen price to $349. The $1,349.02 list price is the price before discounts, and it is rarely the price a cash buyer should pay.
From January 1, 2027, Novo Nordisk cuts the list price of the 2.4 mg injection and the 25 mg pill to $675 a month, while the NovoCare self-pay prices are not affected. Like other cash-pay medical costs, the price depends heavily on the route used to buy, as the guide to how much an MRI costs without insurance shows for imaging.
Ways to Pay Less Without Insurance
The cheapest legitimate route for most cash buyers is NovoCare Pharmacy: get a prescription, order through NovoCare, and pay the self-pay price. The 25 mg pill costs $299 a month there, against $349 for the pen at 2.4 mg, so the pill is $50 a month cheaper at maintenance.
The dose step-up also makes the first three months cheaper. The first month at 1.5 mg costs $149, the second at 4 mg costs $199, and the third at 9 mg costs $299, for a total of $647. From the fourth month, at 25 mg, the cost is $299 a month.
Medicare offers a separate route. The Part D GLP-1 Bridge pilot, running from July 1, 2026 through December 31, 2027, charges a flat $50 a month for Wegovy for Part D members whose plans opt in. The $50 does not count toward the Part D deductible or the out-of-pocket cap, and ordinary Part D does not cover drugs used only for weight loss. From January 1, 2027, the Centers for Medicare and Medicaid Services negotiated a Maximum Fair Price of $385 a month for Wegovy, which governs what Medicare pays, not the copay at the pharmacy counter.
Before paying anything, ask the health plan whether it covers Wegovy at all: many plans exclude weight-loss medicines, while some cover them with prior authorization. Compare retail pharmacies too, since cash prices vary, and use the medical cost estimator to put the monthly drug cost beside other out-of-pocket costs. The guide to how much an ER visit costs without insurance shows how wide the gap between list prices and real prices can be.
Worked Example: 12 Months of the 25 mg Pill
This illustrative example uses the published NovoCare self-pay price and the published list price, and assumes 12 months at the 25 mg maintenance dose with no other discounts.
At the NovoCare self-pay price of $299 a month, 12 months cost $299 times 12, which equals $3,588 a year. At the list price of $1,349.02 a month, 12 months cost $1,349.02 times 12, which equals $16,188.24 a year. The difference is $16,188.24 minus $3,588, which equals $12,600.24 a year.
For comparison, 12 months of the pen at $349 a month cost $349 times 12, which equals $4,188 a year, or $600 a year more than the pill.
The example shows why the buying route matters more than the dose. The medicine is the same either way, but the yearly bill falls from over $16,000 to under $3,600 through the manufacturer’s direct pharmacy instead of a retail pharmacy at list price.
Common Mistakes to Avoid
- Paying the retail list price without checking NovoCare. A regular pharmacy can charge $1,349 to $1,599 a month for the same pill NovoCare sells for $149 to $299.
- Using the old $499 price. Some older pages still quote $499 a month for the pen, the NovoCare price at its March 2025 launch. The current pen price is $349 a month, and the pill starts at $149.
- Breaking the morning routine. The pill is taken on an empty stomach with a small amount of water, then a 30-minute wait before food, drinks, or other pills.
- Buying pills that are not FDA approved. Only Wegovy tablets are FDA approved as a semaglutide pill for weight management; compounded semaglutide and other unapproved forms sold online are not the same product.
- Budgeting only for the starter doses. The first month costs $149 and the second $199, but the maintenance dose costs $299 a month, so a budget built on starter prices runs short from the fourth month.
Pros and Cons
Pros:
- No injection: a once-daily tablet instead of a weekly pen.
- Cheaper than the pen at maintenance through NovoCare, at $299 a month against $349.
- Lower early cost, with the first month at $149 and the second at $199.
- Medicare Bridge route at $50 a month for eligible Part D members.
Cons:
- Strict daily routine: empty stomach, a small amount of water, and a 30-minute wait before food, drinks, or other pills.
- Still expensive without insurance: $3,588 a year at the NovoCare self-pay price for the 25 mg dose.
- List price matches the pen at $1,349.02 a month, so retail buyers get no discount from choosing the pill.
- Many insurance plans exclude weight-loss medicines, so the cash price is often the only price.
Frequently Asked Questions
Can I get Wegovy pills without insurance?
Yes. NovoCare Pharmacy sells the pills to cash buyers at $149 a month for 1.5 mg, $199 for 4 mg, and $299 for 9 mg and 25 mg. A prescription is still required. Retail pharmacies charge about $1,349 to $1,599 a month.
Are Wegovy pills the same as Rybelsus?
No. Both contain oral semaglutide, but they are different products. Rybelsus is approved only for type 2 diabetes. Wegovy tablets are approved for weight management at doses up to 25 mg daily.
How much does the 25 mg Wegovy pill cost per month?
Through NovoCare Pharmacy, the 25 mg pill costs $299 a month. The list price is $1,349.02 a month, and retail cash runs about $1,349 to $1,599. From January 1, 2027, the list price falls to $675 a month, while the NovoCare self-pay price is not affected.
Does Medicare cover Wegovy pills?
Ordinary Medicare Part D does not cover drugs used only for weight loss. The separate GLP-1 Bridge pilot charges a flat $50 a month for Wegovy for Part D members whose plans opt in, from July 1, 2026 through December 31, 2027. The $50 does not count toward the Part D deductible or the out-of-pocket cap.
Wegovy pills change the question for anyone paying cash. The drug is no longer injection-only, and the price is no longer a single number: at list price it costs over $16,000 a year, while through the manufacturer’s own pharmacy the same 25 mg pill costs $3,588 a year. Before filling a prescription, check the NovoCare self-pay price, check whether the plan covers it, and check the Medicare Bridge for Part D members. The same habit helps with every cash-pay bill, as the guide to how much a colonoscopy costs without insurance shows.
Sources: the FDA approval of Wegovy tablets on December 22, 2025 and the OASIS 4 results are covered in AJMC coverage of oral semaglutide. NovoCare prices, the list price, and the retail cash range are set out in a 2026 Wegovy price breakdown. The Medicare GLP-1 Bridge and the 2027 negotiated price are explained in a guide to Medicare coverage of Wegovy.
Sources and methodology
The figures, rules, and rates in this guide come from the authoritative sources linked throughout the article, including ajmc.com, peptides-enhanced.com, telehealth.help. Where a figure is an estimate or a worked example, the article says so.






